Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary

Chronoscale

27/04/2023 22:43

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of 31 cents per share.
    * Revenue rose 60.6% to $4.12 million from a year ago;
analysts
expected $2.80 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 33 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had fallen by 15.2% this
quarter and gained 17.6% so far this year.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 27 at 09:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.31          -0.33          Missed
 Sep. 30 2022      -0.24          -0.33          Missed
 Jun. 30 2022      -0.24          -0.23          Beat